Katwijk Chemie Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SULFACETAMIDE/SULFACETAMIDE SODIUM, with a corresponding US DMF Number 5390.
Remarkably, this DMF maintains an Active status since its submission on June 06, 1984, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 13, 2014, and payment made on June 05, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II